Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | NUVB |
---|---|---|
09:32 ET | 36527 | 3.205 |
09:34 ET | 300 | 3.19 |
09:36 ET | 1439 | 3.1621 |
09:38 ET | 1181 | 3.18 |
09:39 ET | 2671 | 3.21 |
09:41 ET | 100 | 3.23 |
09:43 ET | 700 | 3.21 |
09:45 ET | 13193 | 3.185 |
09:48 ET | 250 | 3.185 |
09:50 ET | 300 | 3.185 |
09:52 ET | 559 | 3.185 |
09:54 ET | 4508 | 3.18 |
09:56 ET | 300 | 3.18 |
09:57 ET | 2149 | 3.175 |
09:59 ET | 26577 | 3.185 |
10:01 ET | 1181 | 3.185 |
10:03 ET | 100 | 3.18 |
10:06 ET | 602 | 3.185 |
10:08 ET | 1960 | 3.175 |
10:10 ET | 7885 | 3.19 |
10:12 ET | 100 | 3.2 |
10:14 ET | 1441 | 3.195 |
10:15 ET | 4039 | 3.175 |
10:19 ET | 1268 | 3.165 |
10:21 ET | 100 | 3.165 |
10:24 ET | 100 | 3.17 |
10:26 ET | 1402 | 3.16 |
10:28 ET | 10599 | 3.155 |
10:30 ET | 100 | 3.15 |
10:32 ET | 8323 | 3.155 |
10:33 ET | 1122 | 3.155 |
10:35 ET | 695 | 3.155 |
10:37 ET | 5038 | 3.165 |
10:39 ET | 189 | 3.165 |
10:42 ET | 5836 | 3.15 |
10:44 ET | 3649 | 3.16 |
10:46 ET | 853 | 3.15 |
10:48 ET | 300 | 3.155 |
10:50 ET | 1255 | 3.155 |
10:51 ET | 13526 | 3.155 |
10:53 ET | 6466 | 3.15 |
10:55 ET | 200 | 3.16 |
10:57 ET | 200 | 3.155 |
11:00 ET | 800 | 3.155 |
11:02 ET | 310 | 3.155 |
11:04 ET | 85230 | 3.13 |
11:06 ET | 10664 | 3.13 |
11:08 ET | 2924 | 3.115 |
11:09 ET | 2919 | 3.1003 |
11:13 ET | 15819 | 3.105 |
11:18 ET | 10794 | 3.105 |
11:22 ET | 7529 | 3.11 |
11:24 ET | 6296 | 3.115 |
11:26 ET | 1765 | 3.105 |
11:27 ET | 100 | 3.1 |
11:29 ET | 5840 | 3.095 |
11:31 ET | 356 | 3.095 |
11:33 ET | 2210 | 3.095 |
11:36 ET | 600 | 3.1 |
11:38 ET | 5336 | 3.105 |
11:40 ET | 200 | 3.105 |
11:42 ET | 300 | 3.105 |
11:44 ET | 11104 | 3.1 |
11:47 ET | 2075 | 3.105 |
11:49 ET | 6625 | 3.11 |
11:51 ET | 5065 | 3.115 |
11:54 ET | 1500 | 3.115 |
11:56 ET | 739 | 3.12 |
11:58 ET | 6686 | 3.13 |
12:00 ET | 1052 | 3.13 |
12:02 ET | 8996 | 3.15 |
12:03 ET | 400 | 3.15 |
12:05 ET | 5391 | 3.14 |
12:07 ET | 1463 | 3.14 |
12:09 ET | 2996 | 3.14 |
12:16 ET | 100 | 3.15 |
12:18 ET | 1738 | 3.145 |
12:20 ET | 500 | 3.15 |
12:21 ET | 11213 | 3.145 |
12:23 ET | 2200 | 3.145 |
12:30 ET | 100 | 3.145 |
12:32 ET | 1800 | 3.15 |
12:34 ET | 300 | 3.15 |
12:36 ET | 100 | 3.145 |
12:38 ET | 397 | 3.145 |
12:39 ET | 600 | 3.145 |
12:41 ET | 100 | 3.15 |
12:45 ET | 200 | 3.145 |
12:48 ET | 24456 | 3.115 |
12:50 ET | 16369 | 3.1 |
12:52 ET | 1868 | 3.1 |
12:54 ET | 200 | 3.1 |
12:56 ET | 4334 | 3.1 |
12:57 ET | 2200 | 3.1 |
12:59 ET | 1000 | 3.1 |
01:01 ET | 10158 | 3.105 |
01:03 ET | 6423 | 3.105 |
01:06 ET | 20020 | 3.12 |
01:08 ET | 4172 | 3.12 |
01:10 ET | 2834 | 3.11 |
01:12 ET | 6287 | 3.105 |
01:14 ET | 2323 | 3.1 |
01:17 ET | 650 | 3.1 |
01:19 ET | 8791 | 3.095 |
01:21 ET | 100 | 3.095 |
01:24 ET | 200 | 3.095 |
01:26 ET | 44469 | 3.085 |
01:28 ET | 1324 | 3.085 |
01:30 ET | 100 | 3.085 |
01:32 ET | 47666 | 3.06 |
01:33 ET | 3819 | 3.065 |
01:37 ET | 9636 | 3.08 |
01:39 ET | 3100 | 3.09 |
01:42 ET | 2000 | 3.09 |
01:44 ET | 7696 | 3.06 |
01:46 ET | 200 | 3.06 |
01:48 ET | 3950 | 3.07 |
01:50 ET | 442 | 3.075 |
01:53 ET | 200 | 3.075 |
01:55 ET | 1225 | 3.08 |
01:57 ET | 1900 | 3.08 |
02:00 ET | 1300 | 3.075 |
02:02 ET | 1170 | 3.08 |
02:04 ET | 800 | 3.075 |
02:06 ET | 17861 | 3.07 |
02:08 ET | 9199 | 3.055 |
02:09 ET | 1993 | 3.05 |
02:11 ET | 200 | 3.05 |
02:13 ET | 300 | 3.05 |
02:15 ET | 1950 | 3.055 |
02:18 ET | 73486 | 3.03 |
02:20 ET | 9203 | 3.025 |
02:22 ET | 69399 | 3.015 |
02:24 ET | 118117 | 3.02 |
02:26 ET | 5244 | 3.005 |
02:27 ET | 5604 | 3.02 |
02:29 ET | 29073 | 3 |
02:31 ET | 7062 | 3.01 |
02:33 ET | 3897 | 3.005 |
02:36 ET | 6221 | 3.015 |
02:38 ET | 200 | 3.015 |
02:40 ET | 500 | 3.02 |
02:42 ET | 3020 | 3.02 |
02:44 ET | 30883 | 2.995 |
02:45 ET | 6689 | 2.985 |
02:47 ET | 30323 | 3 |
02:49 ET | 32259 | 3 |
02:51 ET | 44112 | 3.005 |
02:54 ET | 1440 | 3.005 |
03:00 ET | 2522 | 3.01 |
03:02 ET | 10366 | 3 |
03:03 ET | 2732 | 3.01 |
03:05 ET | 3266 | 3.005 |
03:07 ET | 1733 | 3.005 |
03:09 ET | 5512 | 3.01 |
03:12 ET | 2929 | 3.005 |
03:14 ET | 1300 | 3.01 |
03:16 ET | 2983 | 3.005 |
03:18 ET | 900 | 3.005 |
03:20 ET | 2600 | 3.005 |
03:21 ET | 4299 | 3 |
03:23 ET | 2234 | 3.005 |
03:25 ET | 33272 | 2.99 |
03:27 ET | 4979 | 2.99 |
03:30 ET | 863 | 2.995 |
03:32 ET | 1354 | 2.99 |
03:34 ET | 20173 | 2.99 |
03:36 ET | 2291 | 2.99 |
03:38 ET | 1100 | 2.995 |
03:39 ET | 205 | 2.995 |
03:41 ET | 49089 | 3.005 |
03:43 ET | 3568 | 3.005 |
03:45 ET | 7565 | 3.005 |
03:48 ET | 30469 | 3.01 |
03:50 ET | 29689 | 3 |
03:52 ET | 37957 | 3 |
03:54 ET | 52396 | 2.995 |
03:56 ET | 46727 | 2.995 |
03:57 ET | 10417 | 2.995 |
03:59 ET | 200295 | 3 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Nuvation Bio Inc | 837.9M | -9.5x | --- |
89Bio Inc | 854.0M | -4.2x | --- |
Cogent Biosciences Inc | 858.6M | -3.5x | --- |
CARGO Therapeutics Inc | 807.8M | -5.4x | --- |
Olema Pharmaceuticals Inc | 807.1M | -7.1x | --- |
Perspective Therapeutics Inc | 805.8M | -7.8x | --- |
Nuvation Bio Inc. is a biopharmaceutical company. The Company is engaged in tackling the unmet needs in oncology by developing differentiated and therapeutic candidates. The Company is advancing multiple clinical-stage candidates, including a ROS1 inhibitor, a mutant isocitrate dehydrogenase 1 (mIDH1) inhibitor, a bromodomain and extra-terminal (BET) inhibitor, and a drug-drug conjugate (DDC). Its portfolio of development candidates includes taletrectinib (ROS1), safusidenib (mIDH1), NUV-868 (BET), and NUV-1511 (DDC). Taletrectinib is an oral, potent, CNS-active, selective, ROS1 inhibitor specifically designed for the potential treatment of ROS1-positive non-small cell lung cancer (NSCLC). Safusidenib is an oral, potent, targeted inhibitor of mIDH1 being evaluated in a global Phase II trial in patients with low-grade IDH1-mutant glioma. NUV-868 is a BD2-selective oral small molecule BET inhibitor, that inhibits BRD4. It is conducting Phase I/II study of NUV-1511.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $837.9M |
---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 247.2M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.42 |
EPS | $-0.31 |
Book Value | $2.76 |
P/E Ratio | -9.5x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.